14-20033990-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001004714.2(OR4K13):āc.769A>Gā(p.Ile257Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000644 in 1,614,010 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001004714.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR4K13 | NM_001004714.2 | c.769A>G | p.Ile257Val | missense_variant | 2/2 | ENST00000641904.1 | |
OR4K13 | NM_001386029.1 | c.769A>G | p.Ile257Val | missense_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR4K13 | ENST00000641904.1 | c.769A>G | p.Ile257Val | missense_variant | 2/2 | NM_001004714.2 | P1 | ||
OR4K13 | ENST00000641664.1 | c.769A>G | p.Ile257Val | missense_variant | 2/2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152092Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000838 AC: 21AN: 250624Hom.: 1 AF XY: 0.0000960 AC XY: 13AN XY: 135436
GnomAD4 exome AF: 0.0000650 AC: 95AN: 1461800Hom.: 1 Cov.: 34 AF XY: 0.0000756 AC XY: 55AN XY: 727202
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152210Hom.: 0 Cov.: 31 AF XY: 0.0000806 AC XY: 6AN XY: 74412
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 01, 2024 | The c.769A>G (p.I257V) alteration is located in exon 1 (coding exon 1) of the OR4K13 gene. This alteration results from a A to G substitution at nucleotide position 769, causing the isoleucine (I) at amino acid position 257 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at